½ÃÀ庸°í¼­
»óǰÄÚµå
1792304

ºê¶óŰÅ×¶óÇÇ ½ÃÀå º¸°í¼­ : ¼­ºñ½º À¯Çü, ±â¼ú, Á¶´Þ ¹æ¹ý, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)

Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others ), Technology, Mode of Procurement, End-User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 149 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå ±Ô¸ð´Â 2024³â 8¾ï 8,810¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 12¾ï 1,590¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 3.55%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

ºê¶óŰÅ×¶óÇÇ(³»ºÎ ¹æ»ç¼± Ä¡·á)´Â ¹æ»ç¼±À» ¾Ï Á¾¾ç ±Ùó³ª ÇâÈÄ ÀÌ½ÄµÈ ¹æ»ç¼±¿øÀ» ÅëÇØ Á÷Á¢ Àü´ÞÇÏ´Â ¹æ»ç¼± Ä¡·áÀÇ ÇÑ ÇüÅÂÀÔ´Ï´Ù. ÀÌ ¿øÀº °¨¸¶¼±À» ¹æÃâÇÏ¿© ¾Ï ¼¼Æ÷¿¡ ÁýÁß½ÃÄÑ ÁÖº¯ °Ç°­ÇÑ Á¶Á÷ÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ºê¶óŰÅ×¶óÇÇ´Â Áúº´ÀÇ ½É°¢¼º°ú ¼Õ»ó Á¤µµ¿¡ µû¶ó Àú¼±·®·ü(LDR) ¶Ç´Â °í¼±·®·ü(HDR)·Î Åõ¿©µË´Ï´Ù. LDRÀÇ °æ¿ì, ÀÛÀº ¹æ»ç¼º Á¾ÀÚ°¡ Á¾¾ç ³» ¶Ç´Â ÁÖº¯¿¡ ¿µ±¸ÀûÀ¸·Î À̽ĵǸç, HDRÀÇ °æ¿ì °¢ ¼¼¼Ç Á¾·á ½Ã ȯÀÚÀÇ ¸ö¿¡¼­ ¹æ»ç¼º ¿øÀ» Á¦°ÅÇÏ¿© °íÀ§Çè ¾Ï ÀÌ¿ë »ç·Ê¿¡ »ç¿ëµË´Ï´Ù.

´Ù¾çÇÑ À¯ÇüÀÇ ¾Ï ¹ß»ý·ü Áõ°¡°¡ Àü ¼¼°èÀÇ ½ÃÀåÀÇ ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀڱðæºÎ¾Ï, ÇǺξÏ, À¯¹æ¾Ï Ä¡·á¿¡ ±ØÈ÷ È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ¸·Î ÀÔÁõµÈ ºê¶óŰÅ×¶óÇÇ´Â ½ÃÀå ¼ºÀå¿¡ »ó´çÇÏ°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÛÀº Á¾¾ç¿¡ Á¤È®ÇÏ°í ±ØÈ÷ ±¹¼ÒÈ­µÈ ¹æ»ç¼± ¿ë·®À» Á¦°øÇÏ´Â °íǰÁú ºê¶óŰÅ×¶óÇÇ ÀåºñÀÇ °¡¿ë¼ºÀº ȯÀÚ ¹× ÀÇ·á Àü¹®°¡ ¸ðµÎ¿¡°Ô Ä¡·á¹ý ¼ö¿ëµµ¸¦ ³ô¿´½À´Ï´Ù. Á¾¾ç Ä¡·á ºÐ¾ßÀÇ ±â¼úÀû ¹ßÀü°ú ±¤¹üÀ§ÇÑ ¿¬±¸ °³¹ß(R&D), ¿¹¸¦ µé¾î ½Å»ýÇ÷°ü¼º ¿¬·É °ü·Ã Ȳ¹Ýº¯¼º Ä¡·á¸¦ À§ÇÑ ÀÓ»ó ½ÃÇè µîÀº ½ÃÀå ¼ºÀå¿¡ »ó´çÇÑ ±â¿©¸¦ Çß½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°èÀûÀÎ ÀÇ·á °ü±¤ÀÇ Áõ°¡, ºê¶óŰÅ×¶óÇÇÀÇ ÀåÁ¡°ú ¼ö¼ú ¶Ç´Â ¿ÜºÎ ¹æ»ç¼± Ä¡·á(EBT)¿¡ ºñÇØ ºñ¿ë È¿À²¼º°ú Ä¡·áÀ² Çâ»ó µî¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

IMARC GroupÀÇ ÃֽŠº¸°í¼­´Â Àü ¼¼°è ºê¶óŰÅ×¶óÇÇ ½ÃÀåÀÇ ¸ðµç Çʼö ¿ä¼Ò¸¦ Æ÷°ýÇÏ´Â ±íÀº ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. º» º¸°í¼­´Â ½ÃÀå Àü¹ÝÀÇ °Å½ÃÀû °³¿äºÎÅÍ »ê¾÷ ¼º°ú, ÃÖ±Ù Æ®·»µå, ÁÖ¿ä ½ÃÀå ÃËÁø ¿äÀÎ ¹× µµÀü °úÁ¦, SWOT ºÐ¼®, Æ÷ÅÍÀÇ 5·Â ºÐ¼®, °¡Ä¡ »ç½½ ºÐ¼® µî¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ³»¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. º» º¸°í¼­´Â »ê¾÷ ¾÷ü, ÅõÀÚÀÚ, ¿¬±¸¿ø, ÄÁ¼³ÅÏÆ®, ºñÁî´Ï½º Àü·«°¡, ±×¸®°í Àü ¼¼°è ºê¶óŰÅ×¶óÇÇ ½ÃÀå¿¡ ÁøÃâÇϰųª °ü·Ã °èȹÀ» °¡Áø ¸ðµç À̵鿡°Ô ÇʼöÀûÀÎ ÀÚ·áÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2024³â ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå ±Ô¸ð´Â?
  • 2025-2033³âÀÇ ºê¶óŰÅ×¶óÇÇ ¼¼°èÀÇ ½ÃÀå ¿¹Ãø ¼ºÀå·üÀº?
  • ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå¿¡¼­ COVID-19ÀÇ ¿µÇâÀº?
  • ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå¿¡¼­ ÃÖÁ¾ »ç¿ëÀÚº° ±¸ºÐÀº?
  • ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå¿¡¼­ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ºÐ¼® : ¼­ºñ½º À¯Çüº°
  • ½ÃÀå ºÐ¼® : ±â¼úº°
  • ½ÃÀå ºÐ¼® : Á¶´Þ ¹æ¹ýº°
  • ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
  • ½ÃÀå ºÐ¼® : Áö¿ªº°
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : ¼­ºñ½º À¯Çüº°

  • º´·Â ¹× ½Åü ¼Ò°ß º¸°í¼­
  • Åð¿ø ¿ä¾à
  • ¼ö¼ú ±â·Ï
  • ÇùÀÇ º¸°í¼­
  • ±âŸ

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • ÀüÀÚ ÀÇ·á ±â·Ï
  • È­»ó Åë½Å ½Ã½ºÅÛ
  • RIS
  • SRT
  • ±âŸ

Á¦8Àå ½ÃÀå ³»¿ª : Á¶´Þ ¹æ¹ýº°

  • ¾Æ¿ô¼Ò½Ì
  • ¿ÀÇÁ¼î¾î¸µ
  • ¸ðµÎ

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • Ŭ¸®´Ð
  • ÀÓ»ó ½ÇÇè½Ç
  • ÇмúÀÇ·á¼¾ÅÍ
  • ±âŸ

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Acusis Software India Pvt Ltd.
    • Transcend Services, Inc.
    • Naunce Communications, Inc.
    • MModal Global Services Pvt. Ltd.
    • iMedX Information Services Pvt. Ltd.
    • Global Medical Transcription LLC
    • nThrive Solutions LLC
    • MTBC(CareCloud, Inc.)
    • Medi-Script Plus
    • Transtech Medical Solutions LLC
HBR 25.08.26

The global brachytherapy market size reached USD 888.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,215.9 Million by 2033, exhibiting a growth rate (CAGR) of 3.55% during 2025-2033.

Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient's body at the termination of each session and is used in the cases of high-risk cancers.

The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike. Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.

IMARC Group's latest report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.

Key Market Segmentation:

Breakup by Service Type:

  • History and Physical Report
  • Discharge Summary
  • Operative Note or Report
  • Consultation Report
  • Others (Pathology Report, Radiology Report, etc.)

Breakup by Technology:

  • EMR/EHR
  • PACS
  • RIS
  • SRT
  • Others

Breakup by Mode of Procurement:

  • Outsourcing
  • Offshoring
  • Both

Breakup by End-User:

  • Hospitals
  • Clinics
  • Clinical Laboratories
  • Academic Medical Centers
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.

Key Questions Answered in This Report

  • 1.What was the size of the global brachytherapy market in 2024?
  • 2.What is the expected growth rate of the global brachytherapy market during 2025-2033?
  • 3.What are the key factors driving the global brachytherapy market?
  • 4.What has been the impact of COVID-19 on the global brachytherapy market?
  • 5.What is the breakup of the global brachytherapy market based on the end user?
  • 6.What are the key regions in the global brachytherapy market?
  • 7.Who are the key players/companies in the global brachytherapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Brachytherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Service Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Mode of Procurement
  • 5.7 Market Breakup by End User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Service Type

  • 6.1 History and Physical Report
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Discharge Summary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Operative Note or Report
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Consultation Report
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 EMR/EHR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PACS
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 RIS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 SRT
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode of Procurement

  • 8.1 Outsourcing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Offshoring
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Both
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Academic Medical Centers
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acusis Software India Pvt Ltd.
    • 14.3.2 Transcend Services, Inc.
    • 14.3.3 Naunce Communications, Inc.
    • 14.3.4 MModal Global Services Pvt. Ltd.
    • 14.3.5 iMedX Information Services Pvt. Ltd.
    • 14.3.6 Global Medical Transcription LLC
    • 14.3.7 nThrive Solutions LLC
    • 14.3.8 MTBC (CareCloud, Inc.)
    • 14.3.9 Medi-Script Plus
    • 14.3.10 Transtech Medical Solutions LLC
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦